Biopsy Confirmed Glioma Recurrence Predicted by Multi-Modal Neuroimaging Metrics.

ABSTRACT: Histopathological verification is currently required to differentiate tumor recurrence from treatment effects related to adjuvant therapy in patients with glioma. To bypass the complications associated with collecting neural tissue samples, non-invasive classification methods are needed to alleviate the burden on patients while providing vital information to clinicians. However, uncertainty remains as to which tissue features on magnetic resonance imaging (MRI) are useful. The primary objective of this study was to quantitatively assess the reliability of combining MRI and diffusion tensor imaging metrics to discriminate between tumor recurrence and treatment effects in histopathologically identified biopsy samples. Additionally, this study investigates the noise adjuvant radiation therapy

SUBMITTER: Costabile JD 

PROVIDER: S-EPMC6780506 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature